Morgan Stanley’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2
Closed -$2 8016
2023
Q4
$2 Buy
+2
New +$2 ﹤0.01% 7816

Other funds holding CLBTW

Morgan Stanley's CLBTW Position: Q1 2024 in Review

Morgan Stanley sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q1 2024, closing a stake of 2 shares — an estimated $2 sold.

Morgan Stanley first reported a position in CLBTW in Q4 2023 and held it in 1 quarter. The position peaked at $2 in Q4 2023. 23 funds tracked by Wall St. Rank hold CLBTW as of Q1 2024.

  • Morgan Stanley reported no remaining Cellebrite DI Ltd. Warrants position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 2 Cellebrite DI Ltd. Warrants shares in Q1 2024, an estimated $2.
  • Morgan Stanley first reported a position in Cellebrite DI Ltd. Warrants in Q4 2023 and held it in 1 quarter.
  • Morgan Stanley's Cellebrite DI Ltd. Warrants position peaked at $2 in Q4 2023.
  • 23 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.